Your kidneys make an anti-aging protein.
They make less of it every year you live. By the time most people start thinking about longevity, circulating levels have already fallen well below where they were at thirty — and in kidney disease they collapse further still.
That protein is klotho, and it has the strongest claim of any single molecule to being a genuine longevity switch. Delete it in mice and they age fast and die early. Overexpress it and they live longer. That is not marketing copy; it is two of the most cited papers in the aging field.
🔑 Key Takeaways
- Klotho is a protein your kidneys and brain produce, not a peptide you were ever meant to inject.
- The mouse evidence is genuinely striking — deleting it shortens life, adding it extends life. The human evidence is a different story.
- Oral "klotho supplements" cannot contain klotho in any usable form. What they actually contain is covered below.
- The one injectable product on the market is 20 mcg per vial and costs more per milligram than almost anything else in this category.
- There is a specific gene variant that raises natural klotho, and what it does to cognition is the most interesting human finding so far.
This guide covers what klotho is, what the evidence actually supports, why the supplement aisle version does not work, what the injectable costs, and whether any of it is worth acting on yet.
What Is Klotho?
It is a protein, not a peptide.
Klotho is produced mainly in the kidneys and the brain. It exists in two forms: a membrane-bound version that acts as a co-receptor for FGF23 and controls phosphate handling, and a soluble version — the outer portion, cleaved and released into blood — that circulates as a hormone and acts on tissues all over the body.
The soluble form is the one longevity people care about. It suppresses insulin and IGF-1 signalling, which is the same pathway that shows up in nearly every long-lived organism ever studied.
It was named after Klotho, the Greek Fate who spins the thread of life. The name was not modest, and it was not entirely undeserved.
Note on terminology: "klotho peptide" is what people search, but klotho is a full-length protein of roughly 130 kilodaltons. Products sold as klotho are recombinant protein, not synthesised peptide chains like BPC-157 or TB-500. The distinction matters for how it is made, what it costs, and why it cannot be taken orally.
Why Klotho Became a Longevity Target
Two papers did all the work.
In 1997, a group led by Kuro-o published in Nature on a strain of mice with a defect in a then-unknown gene. Those mice developed something close to a caricature of aging: shortened lifespan, arteriosclerosis, osteoporosis, skin atrophy, infertility. The gene was named klotho.
In 2005, Kurosu and colleagues ran the experiment in the other direction in Science. Overexpressing klotho extended lifespan in mice, and it did so by acting as a circulating hormone that dampens insulin and IGF-1 signalling.
Delete it, aging accelerates. Add it, lifespan extends. In a field full of marginal effects, that is an unusually clean pair of results — and it is why klotho keeps reappearing in longevity conversations almost thirty years later.
What the Human Evidence Actually Says
This is where the story gets more careful.
Nobody has injected klotho into people in a published longevity trial. What exists in humans is observational and genetic:
- Levels fall with age. Circulating klotho declines steadily across adulthood, and it drops sharply in chronic kidney disease — consistent with the kidney being the main production site.
- A gene variant raises it. People carrying one copy of the KL-VS variant of the KLOTHO gene have higher circulating klotho. That variant has been linked to better cognitive outcomes, including resilience to cognitive decline.
- Low klotho tracks with worse outcomes. Across kidney, cardiovascular and cognitive research, lower klotho is associated with worse results. Association, not proof of cause.
What is missing is the step that matters commercially: nobody has shown that injecting klotho into a healthy adult raises anything, improves anything, or extends anything. The gap between "this molecule matters in biology" and "buying this vial will help you" is the entire distance of this article.
Do Klotho Supplements Actually Work?
Short answer: there is no oral klotho.
Klotho is a 130 kDa glycoprotein. Swallow it and digestive enzymes treat it exactly like any other dietary protein — they take it apart into amino acids. Nothing recognisable as klotho reaches your bloodstream. This is not a formulation problem anyone has solved; it is basic protein chemistry.
So what is in the bottles marketed as klotho supplements? Generally one of three things:
If a product promises klotho in a capsule, the protein chemistry alone tells you what happened to it. Exercise and kidney health are, unglamorously, the best-supported ways to influence your own klotho.
Klotho Dosage and How It Is Used
There is no established protocol.
No dosing regimen has been validated in humans, because no human trial has been run. What circulates online are extrapolations from lab work, and the honest description of any klotho dose right now is "a guess with a decimal point."
The practical constraint is the vial. The product on the market is 20 micrograms — micrograms, not milligrams. For comparison, a typical BPC-157 vial is 10 milligrams, five hundred times more material. That reflects both how potent the protein is thought to be and how expensive recombinant protein of this size is to manufacture.
Warning: klotho has no approved medical use, no established human dose, and no published safety data in people. Anyone presenting a specific microgram protocol as validated is inventing it. Talk to a clinician before considering it.
Side Effects and What Nobody Knows
The honest answer is that the side effect profile is unknown.
There is no human safety database. What can be reasoned about comes from klotho biology itself:
- Phosphate and mineral handling. Membrane klotho is the FGF23 co-receptor that governs phosphate excretion. Anything that shifts this axis has the potential to affect mineral balance, and that is not a system to nudge casually.
- Insulin and IGF-1 signalling. The proposed longevity mechanism works by suppressing this pathway. Suppressing growth signalling is not universally good — it is the same trade-off that makes IGF-1 reduction a double-edged intervention.
- Immune response to a recombinant protein. Injected proteins of this size can provoke antibody formation. Whether that happens with klotho in humans has not been studied.
Where to Buy Klotho
Very few vendors carry it, and the reason is cost.
Recombinant protein at this size is expensive to produce, which is why a 20 mcg vial is priced where a 10 mg peptide vial would be. BioLongevity Labs lists alphaKlothoLR as a two-vial pair at $499, with a single vial at $250. The two-vial pair is the one to watch: BioLongevity lists it as orderable, with the single vial harder to catch.
If you are drawn to klotho because of the longevity angle, the compounds with actual human dosing behind them are a more sensible starting point — our guides to epithalon and bioregulator peptides cover that ground, and NAD+ has far more human data than klotho does.
Before you buy: klotho is not approved as a medicine anywhere. If you are buying on the strength of the mouse lifespan results, be clear with yourself that you are buying a hypothesis, at roughly $25 per microgram, with no human data behind the dose.
Frequently Asked Questions
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement, medication, or treatment. PeptideDeck may earn a commission from affiliate links at no additional cost to you.